Plasma Progranulin (PGRN)
593-amino-acid secreted growth factor glycoprotein cleaved in lysosomes into individual granulins (A through G) by cathepsin proteases.
Standard vs. Optimal Reference Rangesng/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
50 - 200 ng/mL
General reference distribution across unselected commercial populations.
75 - 160 ng/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Maintains lysosomal acidification, glucocerebrosidase activity, and suppresses microglial neuro-inflammation in the central nervous system.
Differential Diagnosis
Elevated Levels (PGRN High)
- •Systemic acute phase inflammatory response
- •Certain epithelial tumors
Low Levels (PGRN Low)
- •Frontotemporal Lobar Degeneration (GRN mutation with haploinsufficiency, <50 ng/mL)
- •Neuronal Ceroid Lipofuscinosis Type 11 (homozygous loss)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for PGRN
- Targeted organ system imaging or functional dynamic testing related to lysosomal homeostasis & ftld-tdp
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Plasma Progranulin - The New England Journal of Medicine (2021). PMID: 34190124
- [2]PGRN Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Plasma Progranulin (PGRN) into overall healthspan optimization.